GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics

Bibliographic Details
Title: GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics
Authors: Xinxiao Li, Shengnan Guo, Yangyang Sun, Jiangwei Ding, Chao Chen, Yuehui Wu, Peidong Li, Tao Sun, Xinjun Wang
Source: Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-21 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Medicine
Subject Terms: Epilepsy, Genetic epilepsy with febrile seizures plus, Seizures, GABRG2 gene, Mutations, Antiepileptic treatment, Medicine
More Details: Abstract Genetic epilepsy with febrile seizures plus (GEFS+) is a genetic epilepsy syndrome characterized by a marked hereditary tendency inherited as an autosomal dominant trait. Patients with GEFS+ may develop typical febrile seizures (FS), while generalized tonic–clonic seizures (GTCSs) with fever commonly occur between 3 months and 6 years of age, which is generally followed by febrile seizure plus (FS+), with or without absence seizures, focal seizures, or GTCSs. GEFS+ exhibits significant genetic heterogeneity, with polymerase chain reaction, exon sequencing, and single nucleotide polymorphism analyses all showing that the occurrence of GEFS+ is mainly related to mutations in the gamma-aminobutyric acid type A receptor gamma 2 subunit (GABRG2) gene. The most common mutations in GABRG2 are separated in large autosomal dominant families, but their pathogenesis remains unclear. The predominant types of GABRG2 mutations include missense (c.983A → T, c.245G → A, p.Met199Val), nonsense (R136*, Q390*, W429*), frameshift (c.1329delC, p.Val462fs*33, p.Pro59fs*12), point (P83S), and splice site (IVS6+2T → G) mutations. All of these mutations types can reduce the function of ion channels on the cell membrane; however, the degree and mechanism underlying these dysfunctions are different and could be linked to the main mechanism of epilepsy. The γ2 subunit plays a special role in receptor trafficking and is closely related to its structural specificity. This review focused on investigating the relationship between GEFS+ and GABRG2 mutation types in recent years, discussing novel aspects deemed to be great significance for clinically accurate diagnosis, anti-epileptic treatment strategies, and new drug development.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1479-5876
Relation: https://doaj.org/toc/1479-5876
DOI: 10.1186/s12967-024-05387-1
Access URL: https://doaj.org/article/ada87dcb2f184d279f487a3ca01b4607
Accession Number: edsdoj.87dcb2f184d279f487a3ca01b4607
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14795876
DOI:10.1186/s12967-024-05387-1
Published in:Journal of Translational Medicine
Language:English